Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation

被引：26
|
作者：
Deotare, Uday [1 ]
Atenafu, Eshetu G. [2 ]
Loach, David [1 ]
Michelis, Fotios V. [1 ]
Kim, Dennis [1 ]
Thyagu, Santhosh [1 ]
Lipton, Jeffrey H. [1 ]
Messner, Hans A. [1 ]
Viswabandya, Auro [1 ]
机构：
[1] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Med Oncol & Hematol, Allogene Blood & Marrow Transplant Program, Toronto, ON, Canada
[2] Univ Hlth Network, Dept Biostat, Princess Margaret Canc Ctr, Toronto, ON, Canada
来源：
BONE MARROW TRANSPLANTATION | 2018年 / 53卷 / 03期
关键词：
HEMATOPOIETIC-CELL TRANSPLANTATION; HIGH-DOSE CYCLOPHOSPHAMIDE; MARROW-TRANSPLANTATION; SINGLE-AGENT; OPEN-LABEL; MALIGNANCIES; PROPHYLAXIS; BLOOD; MORTALITY; PHASE-3;
D O I：
10.1038/s41409-017-0053-9
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：361 / 365
页数：5
相关论文
共 50 条
  • [1] Reduction of severe acute graft-versus-host disease using a combination of pre transplant anti-thymocyte globulin and post-transplant cyclophosphamide in matched unrelated donor transplantation
    Uday Deotare
    Eshetu G. Atenafu
    David Loach
    Fotios V. Michelis
    Dennis (Dong-Hwan) Kim
    Santhosh Thyagu
    Jeffrey H. Lipton
    Hans A. Messner
    Auro Viswabandya
    [J]. Bone Marrow Transplantation, 2018, 53 : 361 - 365
  • [2] Post-transplant cyclophosphamide versus anti-thymocyte globulin as graft-versus-host disease prophylaxis in haploidentical transplant
    Ruggeri, Annalisa
    Sun, Yuqian
    Labopin, Myriam
    Bacigalupo, Andrea
    Lorentino, Francesca
    Arcese, William
    Santarone, Stella
    Gulbas, Zafer
    Blaise, Didier
    Messina, Giuseppe
    Ghavamzadeh, Ardeshi
    Malard, Florent
    Bruno, Benedetto
    Diez-Martin, Jose Luis
    Koc, Yener
    Ciceri, Fabio
    Mohty, Mohamad
    Nagler, Arnon
    [J]. HAEMATOLOGICA, 2017, 102 (02) : 401 - 410
  • [3] Post-transplant cyclophosphamide versus anti-thymocyte globulin for graft-versus-host disease prevention in haploidentical transplantation for adult acute lymphoblastic leukemia
    Nagler, Arnon
    Kanate, Abraham S.
    Labopin, Myriam
    Ciceri, Fabio
    Angelucci, Emanuele
    Koc, Yener
    Gulbas, Zafer
    Arcese, William
    Tischer, Johanna
    Pioltelli, Pietro
    Ozdogu, Hakan
    Afanasyev, Boris
    Wu, Depei
    Arat, Mutlu
    Peric, Zinaida
    Giebel, Sebastian
    Savani, Bipin
    Mohty, Mohamad
    [J]. HAEMATOLOGICA, 2021, 106 (06) : 1591 - 1598
  • [4] Effective Strategy to Prevent Acute Graft-Versus-Host Disease in Unrelated Donor Allogeneic Hematopoietic Cell Transplants By Using a Combination of Anti-Thymocyte Globulin (ATG), Post-Transplant Cyclophosphamide and Cyclosporine
    Deotare, Uday
    Loach, David
    Michelis, Fotios V.
    Kim, Dennis D.
    Thyagu, Santhosh
    Lipton, Jeffrey H.
    Messner, Hans A.
    Viswabandya, Auro
    [J]. BLOOD, 2016, 128 (22)
  • [5] Comparison of alemtuzumab, anti-thymocyte globulin, and post-transplant cyclophosphamide for graft-versus-host disease and graft-versus-leukemia in murine models
    Mashima, Kiyomi
    Oh, Iekuni
    Fujiwara, Ken
    Izawa, Junko
    Takayama, Norihito
    Nakano, Hirofumi
    Kawasaki, Yasufumi
    Minakata, Daisuke
    Yamasaki, Ryoko
    Morita, Kaoru
    Ashizawa, Masahiro
    Yamamoto, Chihiro
    Hatano, Kaoru
    Sato, Kazuya
    Ohmine, Ken
    Fujiwara, Shin-Ichiro
    Ohno, Nobuhiko
    Kanda, Yoshinobu
    [J]. PLOS ONE, 2021, 16 (01):
  • [6] POST-TRANSPLANT CYCLOPHOSPHAMIDE (PTCY) VERSUS ANTI-THYMOCYTE GLOBULIN (ATG) VERSUS COMBINATION FOR GRAFT-VERSUS-HOST DISEASE PREVENTION IN HAPLOIDENTICAL TRANSPLANTATION FOR ADULT ACUTE MYELOID LEUKEMIA: A REPORT FROM THE EBMT
    Bazarbachi, Abdul-Hamid
    Labopin, Myriam
    Angelucci, Emanuele
    Blaise, Didier
    Ciceri, Fabio
    Arcese, William
    Santarone, Stella
    Koc, Yener
    Bramanti, Stefania
    Kulagin, Alexander
    Kwon, Mi
    Sica, Simona
    Sanz, Jaime
    Brissot, Eolia
    Nagler, Arnon
    Mohty, Mohamad
    [J]. BONE MARROW TRANSPLANTATION, 2023, 58 (SUPP1) : 64 - 65
  • [7] Treatment of severe acute graft-versus-host disease with anti-thymocyte globulin
    Remberger, M
    Aschan, J
    Barkholt, L
    Tollemar, J
    Ringdén, O
    [J]. CLINICAL TRANSPLANTATION, 2001, 15 (03) : 147 - 153
  • [8] Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
    Annalisa Ruggeri
    Myriam Labopin
    Andrea Bacigalupo
    Boris Afanasyev
    Jan J. Cornelissen
    Ahmet Elmaagacli
    Maija Itälä-Remes
    Didier Blaise
    Ellen Meijer
    Yener Koc
    Noel Milpied
    Harry C. Schouten
    Nicolaus Kroeger
    Mohamad Mohty
    Arnon Nagler
    [J]. Journal of Hematology & Oncology, 11
  • [9] Post-transplant cyclophosphamide for graft-versus-host disease prophylaxis in HLA matched sibling or matched unrelated donor transplant for patients with acute leukemia, on behalf of ALWP-EBMT
    Ruggeri, Annalisa
    Labopin, Myriam
    Bacigalupo, Andrea
    Afanasyev, Boris
    Cornelissen, Jan J.
    Elmaagacli, Ahmet
    Itala-Remes, Maija
    Blaise, Didier
    Meijer, Ellen
    Koc, Yener
    Milpied, Noel
    Schouten, Harry C.
    Kroeger, Nicolaus
    Mohty, Mohamad
    Nagler, Arnon
    [J]. JOURNAL OF HEMATOLOGY & ONCOLOGY, 2018, 11
  • [10] Low dose anti-thymocyte globulin reduces chronic graft-versus-host disease incidence rates after matched unrelated donor transplantation
    Tandra, Anand
    Covut, Fahrettin
    Cooper, Brenda
    Creger, Richard
    Brister, Lauren
    McQuigg, Bernadette
    Caimi, Paolo
    Malek, Ehsan
    Tomlinson, Ben
    Lazarus, Hillard M.
    Otegbeye, Folashade
    Kolk, Merle
    de Lima, Marcos
    Metheny, Leland
    [J]. LEUKEMIA & LYMPHOMA, 2018, 59 (07) : 1644 - 1651
12345